Allergan to buy double-chin treatment maker Kythera for $2.1 billion

Deal is expected to give Allergan and entry into the world of male cosmetic treatments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.